Please login to the form below

Not currently logged in
Email:
Password:

Brexit

This page shows the latest Brexit news and features for those working in and with pharma, biotech and healthcare.

NHS seeks 'solution creators' from within pharma

NHS seeks 'solution creators' from within pharma

Addressing IQVIA’s UK Market Access Summit he said: “Not withstanding the cold trade winds of Brexit, which I totally understand, I would content that we are moving into a new

Latest news

  • EMA’s Amsterdam home will not be ready in time EMA’s Amsterdam home will not be ready in time

    EMA’ s Amsterdam home will not be ready in time. Staff will initially move to a temporary building in the city after Brexit. ... It has been estimated that it will be around nine months after Brexit before the final location in Zuidas will be ready -

  • MHRA: No change for pre-Brexit products after UK exits the EU MHRA: No change for pre-Brexit products after UK exits the EU

    There will be no need for pharmaceutical companies in the UK to modify or re-label products launched pre-Brexit once the country leaves the European Union. ... These include the UK regulator giving “adequate notice [to] ensure that companies had

  • Jeux sans frontières Jeux sans frontières

    But, despite its impending Amsterdam move, 2017 has provided pharma with more questions than answers when it come to Brexit. ... That’s particularly true if we try to guess the future shape of UK-EU pharma regulatory relations and the MHRA’s post-

  • Health coverage across state lines Health coverage across state lines

    Turn and face the strange. Brexit and Trumpism have wrought fundamental shifts in the balance of power among the United States, Britain and the European Union. ... Meanwhile, as Britain undergoes Brexit, English-speaking drug companies have been thrown

  • UK pharma welcomes Brexit breakthrough UK pharma welcomes Brexit breakthrough

    UK pharma welcomes Brexit breakthrough. Calls for medicines regulation and supply to be a priority in talks' next stage. ... UK pharma has welcomed last night’s breakthrough in the Brexit talks between the UK and the European Commission (EC) that saw

More from news
Approximately 43 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    Brexit may indeed mean Brexit - but for the European pharmaceutical industry, knowing what it really means is hugely important. ... This is certainly the case with something as complicated and impactful as Brexit.

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Society is growing, the NHS must meet the needs of an ageing population when staff and budgets are stretched and Brexit is causing uncertainty. ... of Brexit, whether they are on an NHS hospital ward or in another part of the European Union.

  • Risky business for pharma Risky business for pharma

    posing the most significant risks overall”, perhaps due to continued enforcement of the UK Bribery Act and the uncertainty caused by Brexit.

  • Academic-industry collaboration in the era of big data Academic-industry collaboration in the era of big data

    However, one UK-specific overarching challenge that is not straightforward to overcome is Brexit. ... But the country needs to make sure that it can maintain this momentum post-Brexit.

  • Brexit talks threaten supply of medical technologies Brexit talks threaten supply of medical technologies

    Brexit talks threaten supply of medical technologies. As concern grows that the outcome could undermine the regulatory framework. ... These transition periods are already looking tight and are further complicated by the regulatory uncertainty that comes

More from intelligence
Approximately 14 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics